L7 Hitech Private Limited
Medico Remedies Ltd · NSE
+4,30,000 sh · ₹2.08 Cr
FII holding ~flat QoQ
Jun 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 62.6%, Sep 2025 61.4%, Dec 2025 61.4%, Mar 2026 61.4%.
FII
— −0.5pp
FII holding by quarter: Jun 2025 0.1%, Sep 2025 0.3%, Dec 2025 0.5%, Mar 2026 0.0%.
DII
— 0.0pp
L7 Hitech Private Limited
Medico Remedies Ltd · NSE
+4,30,000 sh · ₹2.08 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
8 announcements on record for this company.
DII holding by quarter: Jun 2025 0.0%, Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Jun 2025 62.6%, Sep 2025 61.4%, Dec 2025 61.4%, Mar 2026 61.4%.
FII
— −0.5pp
FII holding by quarter: Jun 2025 0.1%, Sep 2025 0.3%, Dec 2025 0.5%, Mar 2026 0.0%.
DII
— 0.0pp
DII holding by quarter: Jun 2025 0.0%, Sep 2025 0.0%, Dec 2025 0.0%, Mar 2026 0.0%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
8 announcements on record for this company.